Clinical Trial Update: Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating KHK7791 in patients with hyperphosphatemia on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia

Drugs mentioned

• KHK7791

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Hyperphosphatemia | Phase 3 | Status: COMPLETED